Changes in Treatment-Naive Pigment Epithelial Detachments Associated With the Initial Anti–Vascular Endothelial Growth Factor Injection

Authors:

Abstract
Pigment epithelial detachment (PED) is characterized by retinal pigment epithelium separation from the Bruch membrane and can be found in 63% to 80% of eyes with neovascular age-related macular degeneration (nAMD).1-4 The HARBOR trial of ranibizumab in nAMD enrolled treatment-naive patients with subfoveal choroidal neovascularization. At baseline, 54.5% of patients had PED.5 The HARBOR trial was the largest study to our knowledge to use higher-resolution spectral-domain optical coherence tomography (OCT). The objective of this post hoc analysis was to describe changes in treatment-naive PEDs following first anti–vascular endothelial growth factor (VEGF) injection and investigate whether early response is associated with treatment needs/vision outcomes at 2 years.

This publication has 9 references indexed in Scilit: